Petru E, Pickel H, Tamussino K, Lahousen M, Heydarfadai M, Posawetz W, Jakse R
Department of Obstetrics and Gynecology, University of Graz, Austria.
Gynecol Oncol. 1991 Dec;43(3):262-4. doi: 10.1016/0090-8258(91)90032-z.
To study scalene lymph node involvement in ovarian cancer, 37 patients with this disease underwent pretherapeutic open sampling of the left scalene fat tissue. Only 1 patient had a palpable supraclavicular mass. Positive scalene nodes were found in 7 (22%) of 32 patients with stage III or IV disease. Three of four patients with positive scalene nodes also had both positive pelvic and positive paraaortic nodes; one patient with stage IV disease had negative pelvic and paraaortic nodes. Demonstration of scalene node involvement per se currently does not alter the management of patients with ovarian cancer, although patients with occult involvement of the scalene nodes could be considered ineligible for intraperitoneal chemotherapy.
为研究卵巢癌患者斜角肌淋巴结受累情况，37例卵巢癌患者在治疗前接受了左侧斜角肌脂肪组织的开放性活检。仅有1例患者可触及锁骨上肿块。在32例Ⅲ期或Ⅳ期患者中，7例（22%）发现斜角肌淋巴结阳性。4例斜角肌淋巴结阳性患者中有3例盆腔淋巴结和腹主动脉旁淋巴结也为阳性；1例Ⅳ期患者盆腔淋巴结和腹主动脉旁淋巴结为阴性。目前，斜角肌淋巴结受累本身的发现并不会改变卵巢癌患者的治疗方案，不过，隐匿性斜角肌淋巴结受累的患者可被视为不适合接受腹腔化疗。
